Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of WelChol as Add-on to Atorvastatin
NCT00754507Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2002
- Primary completion
- Jun 2003
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia comparing Colesevelam + Atorvastatin with Placebo + Atorvastatin (2 arms). Primary endpoint: Percent change in LDL-C from baseline at 6 weeks. Started Nov 2002; status: completed.
02
Drugs
colesevelam
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00754507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754507.